Chowdhury, I H <br/><br/>
Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy.  [electronic resource] 

 -  Molecular immunology  Feb 2015 
 - 601-2 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1872-9142 
<br/><br/><label>Standard No.: </label>10.1016/j.molimm.2014.09.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--therapeutic use<br/>Cytokines--blood<br/>Female<br/>Humans<br/>Inflammation Mediators--blood<br/>Male<br/>Tuberculosis, Pulmonary--blood